IP rights have nothing to do with slow global rollout of vaccines
IP rights have nothing to do with slow global rollout of vaccines Despite this, some 90 developing nations, led by India and SA, have called for a waiver to suspend all intellectual property rights associated with Covid-19 innovations 17 March 2021 - 05:00 Stephen Ezell Picture: 123RF/SASIRIN PAMAI In the face of a Covid-19 pandemic that has caused 2.6-million fatalities worldwide, life sciences companies have raced to bring forward a wide range of life-saving innovations, including novel diagnostic tests such as that of LumiraDx, which can detect the virus within minut...
Source: businesslive.co.za